Marksans Pharma Limited (BOM:524404)

Marksans Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 27, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	102,062	68,836	31,903	18,627	20,445	5,689
Market Cap Growth	84.14%	115.77%	71.27%	-8.89%	259.35%	-44.29%
Enterprise Value	97,561	63,549	29,746	16,052	19,467	6,163
Last Close Price	225.80	151.24	69.95	44.98	49.16	13.65
PE Ratio	27.71	21.94	11.98	9.97	8.57	4.71
PS Ratio	5.43	3.16	1.72	1.25	1.49	0.50
PB Ratio	5.83	3.30	1.81	1.52	2.26	0.88
P/TBV Ratio	6.20	3.51	1.95	1.67	2.50	1.01
P/FCF Ratio	319.14	17.36	35.20	15.47	3.28
P/OCF Ratio	29.88	13.44	18.77	11.45	2.44
EV/Sales Ratio	3.94	2.92	1.61	1.08	1.42	0.54
EV/EBITDA Ratio	18.85	14.65	9.29	6.68	5.81	3.25
EV/EBIT Ratio	22.65	16.54	10.34	7.50	6.30	3.62
EV/FCF Ratio	294.63	16.19	30.33	14.73	3.55
Debt / Equity Ratio	0.09	0.12	0.07	0.09	0.04	0.05
Debt / EBITDA Ratio	0.38	0.53	0.36	0.43	0.12	0.18
Debt / FCF Ratio	-	11.32	0.67	2.09	0.30	0.20
Asset Turnover	-	0.89	0.97	1.04	1.29	1.33
Inventory Turnover	-	1.94	2.07	1.76	1.87	2.15
Quick Ratio	-	2.99	3.34	2.09	1.62	1.47
Current Ratio	-	4.78	4.91	3.37	3.02	2.60
Return on Equity (ROE)	-	16.35%	17.76%	17.55%	30.69%	20.09%
Return on Assets (ROA)	-	9.86%	9.39%	9.33%	18.13%	12.47%
Return on Capital (ROIC)	11.94%	11.39%	11.16%	11.75%	23.74%	15.80%
Return on Capital Employed (ROCE)	-	16.80%	15.60%	16.70%	33.30%	25.30%
Earnings Yield	3.61%	4.56%	8.35%	10.03%	11.67%	21.22%
FCF Yield	0.31%	5.76%	2.84%	6.46%	30.48%
Dividend Yield	0.27%	0.40%	0.71%	0.56%	0.51%	0.73%
Payout Ratio	0.00%	7.22%	3.82%	5.67%	1.72%	24.43%
Buyback Yield / Dilution	-0.41%	-9.09%	-1.49%	-	0.00%	-
Total Shareholder Return	-0.14%	-8.69%	-0.77%	0.56%	0.51%	0.73%

Updated Feb 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.